Last reviewed · How we verify
Antiseptic Wash
Antiseptic Wash is a Topical antiseptic Small molecule drug developed by Johnson & Johnson Consumer Inc. (J&JCI). It is currently FDA-approved for Skin antisepsis and cleansing, Prevention of minor skin infections, Preoperative skin preparation.
Antiseptic wash kills or inhibits microorganisms on skin through chemical antimicrobial agents.
Antiseptic wash kills or inhibits microorganisms on skin through chemical antimicrobial agents. Used for Skin antisepsis and cleansing, Prevention of minor skin infections, Preoperative skin preparation.
At a glance
| Generic name | Antiseptic Wash |
|---|---|
| Sponsor | Johnson & Johnson Consumer Inc. (J&JCI) |
| Drug class | Topical antiseptic |
| Modality | Small molecule |
| Therapeutic area | Dermatology / Infection Prevention |
| Phase | FDA-approved |
Mechanism of action
Antiseptic washes typically contain active ingredients such as chlorhexidine, benzalkonium chloride, or iodine compounds that disrupt bacterial cell membranes and denature proteins, reducing microbial load on the skin surface. These products are designed for topical use to prevent infection and reduce bacterial colonization in clinical and consumer settings.
Approved indications
- Skin antisepsis and cleansing
- Prevention of minor skin infections
- Preoperative skin preparation
Common side effects
- Skin irritation
- Contact dermatitis
- Dryness
Key clinical trials
- Effect of Antiseptic Irrigations With 0.05% Chlorhexidine Gluconate (Irrisept) Versus Normal Saline on Fasciocutaneous Flap-Based Closure of Pilonidal Disease (NA)
- CLinical Evaluation of ANtiseptic Skin Preparation in Revision Total Joint Arthroplasty of the Hip and Knee (NA)
- Influence of Antiseptic Washes on Wound Healing Complications After THA (NA)
- Pediatric Pilonidal Sinus Surgical Treatment (NA)
- Effectiveness of Screening and Decolonization of S. Aureus to Prevent S. Aureus Surgical Site Infections in Surgery Outpatients
- Staph Intervention for Effective Local Defense (PHASE4)
- Treatment of Acute Periprosthetic Joint Infection Comparing Single and Planned Double-Debridement Antibiotics and Implant Retention Followed by Chronic Antibiotic Suppression (NA)
- Chlorhexidine Antiseptic Irrigation of the Bowel Segment During Radical Cystectomy and Urinary Diversion (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Antiseptic Wash CI brief — competitive landscape report
- Antiseptic Wash updates RSS · CI watch RSS
- Johnson & Johnson Consumer Inc. (J&JCI) portfolio CI
Frequently asked questions about Antiseptic Wash
What is Antiseptic Wash?
How does Antiseptic Wash work?
What is Antiseptic Wash used for?
Who makes Antiseptic Wash?
What drug class is Antiseptic Wash in?
What development phase is Antiseptic Wash in?
What are the side effects of Antiseptic Wash?
Related
- Drug class: All Topical antiseptic drugs
- Manufacturer: Johnson & Johnson Consumer Inc. (J&JCI) — full pipeline
- Therapeutic area: All drugs in Dermatology / Infection Prevention
- Indication: Drugs for Skin antisepsis and cleansing
- Indication: Drugs for Prevention of minor skin infections
- Indication: Drugs for Preoperative skin preparation
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing